Effect of Alcohol Use and Highly Active Antiretroviral Therapy on Plasma Levels of Hepatitis C Virus (HCV) in Patients Coinfected with HIV and HCV
Open Access
- 1 July 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement) , S105-S109
- https://doi.org/10.1086/429506
Abstract
Background. The interactions between human immunodeficiency virus (HIV), hepatitis C virus (HCV), alcohol, and antiretroviral therapy are complex. Methods. We retrospectively assessed persons coinfected with HIV and HCV who achieved HIV suppression to Results. Median HCV RNA levels increased (0.35 log10 IU/mL) at month 3 (n = 44). HCV RNA levels decreased to below baseline by 12 months in patients consuming 0.6 log10 IU/mL) from baseline (P = .04). Conclusions. Because low levels of HCV RNA are predictive of a virological response to therapy for HCV infection, it may be advantageous to first achieve suppression of HIV RNA and then initiate treatment for HCV infection in patients coinfected with HIV and HCV. Excess alcohol consumption with therapy for HIV infection increases HCV RNA levels and may impede the effectiveness of this treatment strategy.Keywords
This publication has 33 references indexed in Scilit:
- Evolution of Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus in Patients Treated with Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2001
- Change in Transaminases in Hepatitis C Virus- and HIV-Coinfected Patients after Highly Active Antiretroviral Therapy: Differences between Complete and Partial Virologic Responders?AIDS Research and Human Retroviruses, 2000
- Increase in Hepatitis C Virus Load in Hemophiliacs during Treatment with Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Chronic hepatitis C: Effect of alcohol on hepatic activity and viral titreJournal of Hepatology, 1996
- Role of endogenous interferon in hepatitis C virus (HGV) infection and in coinfection by HIV and HCVResearch in Virology, 1996
- Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, RitonavirThe Journal of Infectious Diseases, 1996
- Increased Serum Hepatitis C Virus Rna Levels Among Alcoholic Patients With Chronic Hepatitis CHepatology, 1994
- Reconstitution of Long-Term T Helper Cell Function after Zidovudine Therapy in Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1992
- Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatmentClinical and Experimental Immunology, 1992
- Augmentation of Cellular Immune Function during the Early Phase of Zidovudine Treatment of AIDS PatientsThe Journal of Infectious Diseases, 1991